Skip to main content
. 2022 Feb 8;13:838547. doi: 10.3389/fendo.2022.838547

Table 1.

Clinical characteristics and genotype distribution of APOE gene in different groups.

Variables Control T2DM CAD T2DM+CAD
n = 545 n = 264 p n = 401 p n = 204 p
Age (years) 67.2 ± 13.4 69.5 ± 12.7 0.022 65.3 ± 12.3 0.029 70.5 ± 13.0 0.003
Sex
 Female 206 (37.8%) 85 (32.2%) 0.120 111 (27.7%) 0.001 65 (31.9%) 0.132
 Male 339 (62.2%) 179 (67.8%) 290 (72.3%) 139 (68.1%)
Lipid profile (mmol/L)
 TC 4.25 ± 0.96 4.30 ± 1.23 0.974 4.33 ± 1.13 0.635 4.29 ± 1.34 0.385
 TG 1.42 ± 0.91 1.72 ± 1.30 <0.001 1.49 ± 0.89 0.238 1.86 ± 1.45 <0.001
 HDL-C 1.15 ± 0.33 1.05 ± 0.28 <0.001 1.09 ± 0.26 0.032 1.02 ± 0.27 <0.001
 LDL-C 2.58 ± 0.71 2.65 ± 0.89 0.506 2.69 ± 0.86 0.173 2.70 ± 1.03 0.794
TG/HDL-C ratio 1.38 ± 1.12 1.87 ± 1.88 <0.001 1.49 ± 1.10 0.032 2.08 ± 2.13 <0.001
APOE genotypes
 APOE2 ϵ2/ϵ2 6 (1.10%) 3 (1.14%) 1.000 1 (0.25%) 0.249 0 (0%)
ϵ2/ϵ3 87 (15.96%) 47 (17.80%) 0.509 52 (12.97%) 0.198 27 (13.24%) 0.355
 APOE3 ϵ2/ϵ4 6 (1.10%) 2 (0.76%) 1.000 3 (0.75%) 0.741 4 (1.96%) 0.473
ϵ3/ϵ3 387 (71.01%) 171 (64.77%) 0.072 268 (66.83%) 0.169 132 (64.71%) 0.096
 APOE4 ϵ3/ϵ4 58 (10.64%) 39 (14.77%) 0.090 75 (18.70%) <0.001 39 (19.12%) 0.002
ϵ4/ϵ4 1 (0.18%) 2 (0.76%) 1.000 2 (0.50%) 0.577 2 (0.98%) 0.182
APOE alleles
 ϵ2 105 (9.63%) 55 (10.42%) 0.621 57 (7.11%) 0.052 31 (7.60%) 0.222
 ϵ3 919 (84.31%) 428 (81.06%) 0.101 663 (82.67%) 0.340 330 (80.88%) 0.112
 ϵ4 66 (6.06%) 45 (8.52%) 0.066 82 (10.22%) <0.001 47 (11.52%) <0.001

Data are presented as mean ± SD, or numbers (N) and percentage. p-value: comparison between T2DM/CVD/T2DM+CAD group and control group. Groups were compared using Student’s t-test or Wilcox test (for continuous variables) and Pearson’s χ2 test or Fisher’s exact test (for categorical variables). Bold values denote statistical significance at the p < 0.05 level.